How many insider trades does FilingIQ track for TRAX?

FilingIQ tracks 110 Form 4 insider transactions for TRAX (First Tracks Biotherapeutics, Inc.), covering filings from Apr 20, 2026 onwards. 110 of those were filed in the last 90 days.

Are TRAX insiders net buyers or net sellers?

Across the full Form 4 history for TRAX, 0 transactions (0%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TRAX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TRAX in?

First Tracks Biotherapeutics, Inc. (TRAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $655.71M.

TRAX insider trading

NasdaqGS Healthcare

First Tracks Biotherapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

110

Last 90 days

110

Buys / sells

0% / 1%

Market cap

$655.71M

About First Tracks Biotherapeutics, Inc.

First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.

TRAX insider activity at a glance

FilingIQ has scored 110 insider transactions for TRAX since Apr 20, 2026. The most recent filing in our index is dated May 12, 2026.

Across the full history, 0 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TRAX insider trades is 65.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TRAX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for TRAX?: FilingIQ tracks 110 Form 4 insider transactions for TRAX (First Tracks Biotherapeutics, Inc.), covering filings from Apr 20, 2026 onwards. 110 of those were filed in the last 90 days.
Are TRAX insiders net buyers or net sellers?: Across the full Form 4 history for TRAX, 0 transactions (0%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TRAX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TRAX in?: First Tracks Biotherapeutics, Inc. (TRAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $655.71M.

Methodology & sources

Every TRAX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.